| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Isorhamnetin | Diabetes Type 2 | 3 | PM | 38445617 | 📋 | Isorhamnetin as a potential therapeutic agent for diabetes mellitus through PGK1/AKT activation |
| Isorhamnetin | Diabetes Type 2 | 2 | PM | 36677559 | 📋 | Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model |
| Isorhamnetin | Diabetes Type 2 | 1 | PM | 36618710 | 📋 | The mitigative effect of isorhamnetin against type 2 diabetes via gut microbiota regulation in mice |
| Isorhamnetin | Excessive Weight | 1 | PM | 32914113 | 📋 | Fat-lowering effects of isorhamnetin are via NHR-49-dependent pathway in Caenorhabditis elegans |
| Isorhamnetin | Hyperlipidemia | 1 | PM | 32918994 | 📋 | Network pharmacology analysis and experimental validation to explore the mechanism of sea buckthorn flavonoids on hyperlipidemia |
| Isorhamnetin | Iron Overload | 1 | PM | 38795598 | 📋 | Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron |
| Isorhamnetin | Metabolic Disorders | 1 | PM | 34606526 | 📋 | Isorhamnetin attenuates high-fat and high-fructose diet induced cognitive impairments and neuroinflammation by mediating MAPK and NFκB signaling pathways |
| Isorhamnetin | Obesity | 1 | PM | 36613743 | 📋 | Anti-Obesity Effects of Isorhamnetin and Isorhamnetin Conjugates |
